HDAC6 inhibition alleviates acute pulmonary embolism: a possible future therapeutic option.
Tao ZhouDi JiaJiahui HanCe XuXiaohong YouXin GePublished in: Folia histochemica et cytobiologica (2023)
These findings demonstrate that the inhibition of HDAC6 may alleviate lung dysfunction and pathological injury resulting from APE by blocking the AKT/ERK signaling pathway, providing new theoretical fundamentals for APE therapy.
Keyphrases
- pulmonary embolism
- signaling pathway
- pi k akt
- inferior vena cava
- cell proliferation
- histone deacetylase
- epithelial mesenchymal transition
- liver failure
- induced apoptosis
- respiratory failure
- current status
- drug induced
- hepatitis b virus
- stem cells
- intensive care unit
- extracorporeal membrane oxygenation
- smoking cessation
- replacement therapy